View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Vaccination News

SPONSORED CONTENT
Save
SPONSORED CONTENT
December 27, 2022
2 min read
Save

2022 in review: The year in pediatric COVID-19

2022 in review: The year in pediatric COVID-19

As the COVID-19 pandemic enters its 4th year, its effect on children continues to be widely studied. We compiled a list of pediatric COVID-19 stories reported over the course of the past year.

SPONSORED CONTENT
December 27, 2022
1 min read
Save

COVID-19 vaccination does not lower couples’ odds of pregnancy by artificial insemination

COVID-19 vaccination does not lower couples’ odds of pregnancy by artificial insemination

COVID-19 vaccination, regardless of type, was not associated with lower odds of pregnancy by artificial insemination by partner among couples in China, according to data published in JAMA Network Open.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
December 24, 2022
2 min read
Save

Malaria news you may have missed in 2022, including positive vaccine data

Malaria news you may have missed in 2022, including positive vaccine data

Malaria cases and deaths stabilized in 2021 after increasing in 2020 as the mosquito-borne disease took a back seat to COVID-19 and an exploding pandemic.

SPONSORED CONTENT
December 23, 2022
2 min read
Save

Protection from COVID-19 booster lasts at least 3 months in children, study finds

Protection from COVID-19 booster lasts at least 3 months in children, study finds

Protection against the omicron variant from the Pfizer-BioNTech COVID-19 vaccine waned after 3 months in children aged 5 to 11 years but was restored by a booster shot, according to study findings published in JAMA Network Open.

SPONSORED CONTENT
December 22, 2022
8 min read
Save

COVID-19 vaccine manufacturers release positive data on boosters

COVID-19 vaccine manufacturers release positive data on boosters

The manufacturers of the COVID-19 vaccines authorized for use as additional booster shots in the United States all released positive clinical trial data on their retooled shots ahead of the start of the holiday season.

SPONSORED CONTENT
December 21, 2022
2 min read
Save

Severe outcomes most common in unvaccinated inpatients with delta variant COVID-19

Severe outcomes most common in unvaccinated inpatients with delta variant COVID-19

The risk for severe disease or death among U.S. adults with COVID-19 was highest for unvaccinated inpatients and those infected with the delta variant, according to a recent study published in Clinical Infectious Diseases.

SPONSORED CONTENT
December 20, 2022
3 min read
Save

Mucosal vaccines for COVID-19 ‘should be developed and tested’

Mucosal vaccines for COVID-19 ‘should be developed and tested’

Experts argued for the development of COVID-19 vaccines that can be delivered at the site of infection, but questioned whether it is possible to make a mucosal vaccine that prevents SARS-CoV-2 infection — and not just severe disease.

SPONSORED CONTENT
December 20, 2022
1 min read
Save

Top in ID: Free at-home COVID-19 tests; malaria prevalence

Top in ID: Free at-home COVID-19 tests; malaria prevalence

The Biden administration announced that U.S. households will be able to order four free at-home rapid COVID tests from the U.S. Postal Service.

SPONSORED CONTENT
December 19, 2022
3 min read
Save

Paxlovid reduces hospitalization, death risk in vaccinated patients

Paxlovid reduces hospitalization, death risk in vaccinated patients

Real-world data on Paxlovid showed it was associated with a reduced risk for hospitalization or death in outpatients with early COVID-19 “in the context of high vaccination prevalence and an intense omicron epidemic,” researchers reported.

SPONSORED CONTENT
December 16, 2022
2 min read
Save

Studies indicate bivalent boosters reduce risk for severe COVID-19

Studies indicate bivalent boosters reduce risk for severe COVID-19

Findings from two real-world studies published Friday in MMWR indicate that bivalent COVID-19 messenger RNA vaccines reduce the risk for severe outcomes from the disease, including hospitalization.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails